Page last updated: 2024-11-03

primaquine and Paralysis

primaquine has been researched along with Paralysis in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Back, DJ1
Purba, HS1
Staiger, C1
Orme, ML1
Breckenridge, AM1

Other Studies

1 other study available for primaquine and Paralysis

ArticleYear
Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.
    Biochemical pharmacology, 1983, Jan-15, Volume: 32, Issue:2

    Topics: Aminopyrine N-Demethylase; Animals; Antipyrine; Chloroquine; Kinetics; Male; Paralysis; Pentobarbita

1983